Gamma-hydroxybutyrate compositions having improved pharmacokinetics in the fed state
AssigneeFlamel Ireland Limited
InventorsJulien Grassot, Cendrine Grangeon, Jordan Dubow, Jason Vaughn
Life of this patent
Estimating the term…
Abstract
Oral pharmaceutical compositions of sodium oxybate having improved pharmacokinetic properties when administered less than two hours after eating are provided, and therapeutic uses thereof.
Claims45
A method of treating a human patient in need thereof, the method comprising:
- forming a mixture comprising a pharmaceutical composition comprising gamma-hydroxybutyrate and a soft food vehicle;
- and
- orally administering the mixture to the human patient after the forming, wherein the orally administering and the forming occur only once nightly.
A method of treating a disorder treatable with gamma-hydroxybutyrate in a human in need thereof, the method comprising:
- opening a sachet containing a single daily dose of a pharmaceutical composition, wherein the pharmaceutical composition comprises an amount of gamma-hydroxybutyrate equivalent to from 3.0 to 12.0 g of sodium oxybate;
- mixing the pharmaceutical composition with a soft food vehicle;
- and
- orally administering the mixture, wherein the opening, mixing, and orally administering occur only once daily.
A pharmaceutical mixture comprising:
- an immediate release portion comprising gamma-hydroxybutyrate;
- a modified release portion comprising gamma-hydroxybutyrate;
- and
- a soft food vehicle,
- wherein the ratio of gamma-hydroxybutyrate in the immediate release portion and the modified release portion is from 10/90 to 65/35.
A pharmaceutical mixture comprising a soft food vehicle, an immediate release portion, and a modified release portion, wherein the immediate release portion comprises particles comprising gamma-hydroxybutyrate, wherein the modified release portion comprises particles comprising gamma-hydroxybutyrate and a coating, and wherein the coating comprises:
- a polymer carrying free carboxylic groups, and
- a hydrophobic compound having a melting point equal or greater than 40° C.
A method of treating a human patient in need thereof, the method comprising:
- orally administering a pharmaceutical mixture to a human patient, the pharmaceutical mixture comprising a soft food vehicle and a composition comprising amount of gamma-hydroxybutyrate equivalent to from 3.0 g to 12.0 g of sodium oxybate, and wherein the composition comprises immediate-release and modified-release portions, each of which comprises gamma-hydroxybutyrate, and wherein the composition comprises a dry particulate or a powder;
- and
- wherein the orally administering occurs only once nightly, and wherein the composition has a pH of ≤6.0.
A method of treating a human patient in need thereof, the method comprising:
- orally administering a pH-adjusted composition to a human patient, the composition comprising a soft food vehicle and an amount of gamma-hydroxybutyrate equivalent to from 3.0 g to 12.0 g of sodium oxybate, and wherein the composition comprises immediate-release and modified-release portions, each of which comprises gamma-hydroxybutyrate, and wherein the amount of gamma-hydroxybutyrate equivalent to from 3.0 g to 12.0 g of sodium oxybate comprises a dry particulate or a powder;
- wherein the orally administering occurs only once nightly, and wherein the pH of the composition is between 5.0 to 6.0 at administration.
Dependencies are inferred from the claim text.